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Objective: To examine the presence of hepatitis B surface antigen (HBsAg), hepatitis B core
antigen (HBcAg), and hepatitis B virus (HBV) DNA in parotid tissues from patients with positive
serum HBV markers.
Methods: HBsAg and HBcAg were examined in parotid biopsy tissues from patients with suspected
parotid tumor and positive serum HBV markers by immunocytochemistry, and HBV DNA was
detected in parotid tissues by PCR.
Results: Among the 22 patients with a parotid tumor, only one was pathologically confirmed as a
neoplasm; all others were benign. HBsAg and HBcAg were present in parotid cells with positive
rates of 45.5% (10/22) and 40.9% (9/22), respectively, with an overall positive rate of 54.5% (12/
22). Of the 22 cases with serum markers of HBV infection, seven (31.8%) had both HBsAg and
HBcAg in the parotid cells. HBV DNA was present in seven of the 12 samples in which hepatitis B
antigen was detected (58.3%).
Conclusions: HBV in saliva might originate from the infected salivary glands and the infectious
saliva could transmit HBV.
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Figure 1 Detection of HBsAg in parotid tissue by immunocy-
tochemistry (brown particles represent positive HBsAg expres-
sion).
Figure 2 Detection of HBcAg in parotid tissue by immunocy-
tochemistry (brown particles represent positive HBcAg expres-
sion).
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China has a high incidence of hepatitis B infection. The
positive rate of serum hepatitis B surface antigen (HBsAg)
is about 10—15%,1,2 which translates into 120—180 million
active infections in the country. Hepatitis B virus (HBV) can
cause a range of human disorders such as acute hepatitis,
chronic hepatitis, hepatocirrhosis, and hepatocellular carci-
noma.3,4 HBV can cause extrahepatic pathological lesions.
With the advances in molecular techniques, HBV can be
detected in patients with HBV infection in peripheral blood
mononuclear cells, tissues of the pancreas, spleen, skin, and
kidney, and fluids such as saliva, semen, vaginal secretions,
sweat, breast milk, tears, and urine.5—7
Although there have been some studies on the infection
and location of HBV in extrahepatic tissues,8 it remains
controversial whether HBV can replicate outside the liver
after acute infection.6 The results of studies into the location
and distribution of HBV in extrahepatic tissues or cells are not
consistent, and the pathologic lesions caused by extrahepatic
infection with HBV and their pathogenesis are not fully
understood. Little is known about whether HBV exists in
parotid tissues. If we can demonstrate that HBV exists in
parotid tissues, then it is reasonable to assume that the
viruses present in saliva might originate from the salivary
glands. The objective of this study was the detection of
HBsAg, hepatitis B core antigen (HBcAg), and HBV DNA in
parotid biopsy specimens from patients with positive HBV
serum markers, using immunocytochemistry and polymerase
chain reaction (PCR).
Materials and methods
We reviewed the 1992—2003 pathology registry of Xiangya
Hospital, Central South University and identified all patients
who had had a parotid biopsy. Because it is impossible to
obtain parotid tissues from normal individuals, we used the
parotid tissues taken from patients with suspected parotid
tumors for pathological examination.We further selected the
patients with positive serum HBsAg. Paraffin-embedded par-
otid tissues from the patients with positive serum HBsAg were
used for laboratory investigations.
The presence of HBsAg and HBcAg in parotid biopsy tissues
was determined by immunocytochemistry (streptavidin—per-
oxidase—biotin) according to the protocol provided by the
manufacturer. Reagents used were purchased from Zhong-
shan Biological Technology Ltd, Beijing.
For those patients with HBsAg and HBcAg detected in the
parotid tissues, HBV DNA was examined by PCR. Paraffin-
embedded parotid tissues were digested with proteinase K,
and DNA was isolated by phenol and chloroform. Primer
sequences were as follows: forward primer, 50-TCGGAAA-
TACA-CCTCCTTTCCATGG-30; reverse primer, 50-GCCTCAAG-
GTCGGTCGTTGACA-30. The length of the PCR product was
350 bp. Thirty cycles of DNA amplification were performed
in 50 ml PCR reaction mixture. The conditions for each cycle
were: denaturing at 94 8C for 30 s, primer annealing at 55 8C
for 30 s, and elongation at 72 8C for 30 s, followed by a final 10-
min elongation at 72 8C. DNA marker, proteinase K, Taq DNA
polymerase, and dNTP were purchased form TaKaRa Co.,
Dalian. Primer was synthesized by BioAsia Co., Shanghai.This study was approved by the research ethics board of
Central South University.
Results
A total of 232 patients who had had a parotid biopsy were
identified from the pathology registry of the Xiangya Hospi-
tal, Central South University for the period 1992—2003.
Among them, 22 patients had positive serum HBV markers.
All of the 22 patients (11 males and 11 females) had an initial
diagnosis of parotid tumor. Among them, only one was a
pathologically confirmed neoplasm, and all others were
benign. The age of these patients ranged from 2 months to
71 years (median 40 years). All of the 22 patients were
positive for HBsAg in serum, but no other serum HBV marker
was recorded in the original pathology reports.
The results of immunocytochemistry indicated that HBsAg
and HBcAg were present in parotid tissues. Brown positive
particles were found predominantly within the parotid cells,
depositing linearly or in clusters (Figures 1 and 2). HBsAg and
HBcAg were present in parotid cells with positive rates of
45.5% (10/22) and 40.9% (9/22), respectively, with an overall
Figure 3 Detection of HBV DNA in parotid tissue by PCR (M DNA
marker, lanes 1, 2, 5, 7, and 8 were positive samples).
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markers of HBV infection, seven (31.8%) had both HBsAg and
HBcAg in the parotid cells. Because hepatitis B antigen was
detected in the parotid tissue in only 12 cases, HBV DNA was
examined in parotid tissues for these 12 patients only. HBV
DNAwas present in seven of the 12 samples examined (58.3%)
(Figure 3). Because of incomplete data, we could not analyze
the relationship between parotid HBVantigen expression and
serum HBV markers.
Discussion
Transmission of HBV occurs within and between households
through daily contact, and the potential transmission vehi-
cles include saliva.9 HBsAg, HBeAg, and anti-HBe are HBV
markers that can be detected both in saliva and serum.10,11
HBV DNA has been detected in saliva from HBsAg-positive
patients.12 One study has shown positive rates of HBV DNA in
saliva of 64.2% in acute HBV infections and 61.6% in HBV
carriers.13 Another study found a high correlation between
serum HBV DNA and saliva HBV DNA.14 However, there is little
information regarding whether the parotid gland can func-
tion as a site of HBV location and replication. The major
obstacle for research aimed at providing an answer to this
question is the difficulty in obtaining tissues from the salivary
glands.
Our study results indicate that HBsAg, HBcAg, and HBV
DNA were present in parotid tissues, which is consistent with
a previously reported study.15 The findings from our study and
earlier ones suggest that HBV in saliva might originate from
infected salivary glands. In our study, parotid biopsies were
performed following a standard pathology protocol (i.e.,
parotid tissues were washed, antisepticized, and paraffin-
embedded), so that the possibility of a false positive parotid
HBV finding caused by blood contamination was very small.
Although the samples in our study were taken from patients
with suspected parotid tumors, only one was a pathologically
confirmed neoplasm, and all others were benign cases. Even
for the neoplasm case, we used normal parotid tissues for
HBVexamination. As a result, our finding could represent HBV
infection in normal parotid tissues.
The presence of HBsAg and HBcAg in the human body
suggests that the individual can make antibodies, and HBV
antigen and antibody can form immune complexes. If HBsAgand HBcAg are present in tissues, the immune complexes thus
formed can cause pathological lesions in the tissues. When
HBV DNA is present in the tissues, HBV can replicate and
therefore establish infection. Because HBV replication can
increase HBV antigens in the circulation, HBV antigens can
deposit in the tissues leading to tissue immune lesions.16
The presence of antigen and DNA in saliva could decline
after the acute phase. Unfortunately, our study was based on
retrospective parotid tissue samples obtained from the
pathology department. As a result, we could not differenti-
ate acute from chronic infection, nor could we compare viral
load in saliva with that in the parotid. Theoretically, com-
pared with HBsAg and DNA, the presence of HBcAg represents
a higher risk for passing on the infection. However, since we
were not able to look at the presence of antigen in parotid
gland and saliva simultaneously, we could not examine this
issue.
HBV is a partially double-stranded DNA virus of the Hepad-
naviridae family. The length of the HBV genome is 3.2 kb.17
There are several kinds of HBV DNA at different replication
stages, such as HBV covalently closed circular DNA (cccDNA),
relaxed circular DNA (rcDNA), single-stranded DNA, and inte-
grated DNA. In the lifecycle of HBV, cccDNA is a template for
transcription of viral pregenomic RNA and all messenger
RNA.18 cccDNA is a replicative intermediate of HBV DNA,
which sustains the HBV infection in human bodies19 and plays
an important role in HBV replication and the establishment of
HBV infection. However, due to lack of funds, we did not
examine cccDNA in parotid tissues.
In summary, our study based on 22 patients with positive
serum HBVmarkers, suggests that the parotid gland can serve
as a site of HBV location. Whether HBV can replicate in
parotid tissues deserves further investigation. Future studies
on these research questions could lead to the discovery of
potentially new HBV transmission routes and could provide
scientific evidence for the control and prevention of hepatitis
B. For example, if HBV detected in saliva has originated in the
salivary glands instead of blood, HBV transmission could be
realized through intimate contact with HBV-positive indivi-
duals.
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